Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects

NCT02211144 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBR 796 BS
DRUG: Placebo

Sponsor

Boehringer Ingelheim